Karyopharm Therapeutics Inc. (KPTI)

NASDAQ: KPTI · IEX Real-Time Price · USD

0.890

-0.027 (-3.00%)

At close: Jul 19, 2024, 4:00 PM

0.900

+0.010 (1.16%)

Pre-market: Jul 22, 2024, 7:07 AM EDT

Karyopharm Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2011
Revenue	140.46	146.03	157.07	209.82	108.09	40.89	Upgrade
Revenue Growth (YoY)	-5.16%	-7.03%	-25.14%	94.12%	164.31%	34.80%	Upgrade
Cost of Revenue	5.5	4.94	5.21	3.4	2.71	2.41	Upgrade
Gross Profit	134.96	141.09	151.86	206.42	105.38	38.49	Upgrade
Selling, General & Admin	125.52	131.88	145.4	143.85	126.42	105.42	Upgrade
Research & Development	141.84	138.75	148.66	160.84	150.81	122.34	Upgrade
Operating Expenses	267.36	270.63	294.06	304.69	277.23	227.76	Upgrade
Operating Income	-132.4	-129.54	-142.2	-98.27	-171.85	-189.28	Upgrade
Interest Expense / Income	23.95	23.82	25	26.05	27.14	15.65	Upgrade
Other Expense / Income	-10.35	-10.59	-2.28	-0.5	-3.03	-5.37	Upgrade
Pretax Income	-146	-142.78	-164.92	-123.82	-195.96	-199.55	Upgrade
Income Tax	0.34	0.32	0.37	0.27	0.31	0.04	Upgrade
Net Income	-146.34	-143.1	-165.29	-124.09	-196.27	-199.59	Upgrade
Shares Outstanding (Basic)	115	114	82	75	72	62	Upgrade
Shares Outstanding (Diluted)	115	114	82	75	72	62	Upgrade
Shares Change	1.74%	39.51%	8.84%	4.41%	16.28%	9.11%	Upgrade
EPS (Basic)	-1.27	-1.25	-2.02	-1.65	-2.72	-3.22	Upgrade
EPS (Diluted)	-1.27	-1.25	-2.02	-1.65	-2.72	-3.22	Upgrade
Free Cash Flow	-117.73	-92.72	-149.67	-107.33	-160.38	-191.03	Upgrade
Free Cash Flow Per Share	-1.02	-0.81	-1.83	-1.43	-2.23	-3.08	Upgrade
Gross Margin	96.08%	96.62%	96.68%	98.38%	97.50%	94.11%	Upgrade
Operating Margin	-94.26%	-88.71%	-90.53%	-46.84%	-159.00%	-462.85%	Upgrade
Profit Margin	-104.18%	-97.99%	-105.23%	-59.14%	-181.59%	-488.08%	Upgrade
Free Cash Flow Margin	-83.82%	-63.49%	-95.29%	-51.15%	-148.38%	-467.14%	Upgrade
EBITDA	-121.72	-118.42	-139.31	-96.99	-167.85	-182.93	Upgrade
EBITDA Margin	-86.66%	-81.09%	-88.69%	-46.22%	-155.30%	-447.34%	Upgrade
Depreciation & Amortization	0.33	0.53	0.62	0.79	0.97	0.97	Upgrade
EBIT	-122.05	-118.95	-139.93	-97.77	-168.82	-183.9	Upgrade
EBIT Margin	-86.89%	-81.46%	-89.08%	-46.60%	-156.20%	-449.72%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).